Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Oncogene

• Publication date

  2003-07-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1206465PMID 12833144
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sam68 Enhances the Cytoplasmic Utilization of Intron-Containing RNA and Is Functionally Regulated by the Nuclear Kinase Sik/BRK

  2003cited by this paper
• Signal-dependent regulation of splicing via phosphorylation of Sam68

  2002cited by this paper
• Growth factors and their receptors in prostate cancer

  2002cited by this paper
• Inhibition of Human Immunodeficiency Virus Type 1 Rev Function by a Dominant-Negative Mutant of Sam68 through Sequestration of Unspliced RNA at Perinuclear Bundles

  2001cited by this paper
• Oncogenic kinase signalling

  2001cited by this paper
• Stress-induced nuclear bodies are sites of accumulation of pre-mRNA processing factors.

  2001cited by this paper
• The development of androgen-independent prostate cancer

  2001cited by this paper
• Sik (BRK) Phosphorylates Sam68 in the Nucleus and Negatively Regulates Its RNA Binding Ability

  2000cited by this paper
• Molecular genetics of prostate cancer.

  2000cited by this paper
• Dysregulated expression of growth factors and their receptors in the development of prostate cancer

  2000cited by this paper
• A novel adaptor-like protein which is a substrate for the non-receptor tyrosine kinase, BRK

  2000cited by this paper
• A role for the GSG domain in localizing Sam68 to novel nuclear structures in cancer cell lines.

  1999cited by this paper
• Inhibition of HIV replication by dominant negative mutants of Sam68, a functional homolog of HIV-1 Rev

  1999cited by this paper
• The interaction and colocalization of Sam68 with the splicing-associated factor YT521-B in nuclear dots is regulated by the Src family kinase p59(fyn).

  1999cited by this paper
• A Role for Sam68 in Cell Cycle Progression Antagonized by a Spliced Variant within the KH Domain*

  1997cited by this paper
• A role for the epithelial-cell-specific tyrosine kinase Sik during keratinocyte differentiation.

  1997cited by this paper
• STAR, a gene family involved in signal transduction and activation of RNA.

  1997cited by this paper
• Loss of expression of receptor tyrosine kinase family genes PTK7 and SEK in metastatic melanoma

  1997cited by this paper
• BRK tyrosine kinase expression in a high proportion of human breast carcinomas

  1997cited by this paper
• Phosphorylation of the Src substrate Sam68 by Cdc2 during mitosis

  1997cited by this paper
• Growth of an androgen‐sensitive human prostate cancer cell line, LNCaP, in nude mice

  1993cited by this paper
• The LNCaP cell line--a new model for studies on human prostatic carcinoma.

  1980cited by this paper
• Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.

  1974cited by this paper

• Mechanistic insights and clinical implications of RNA-binding proteins in prostate cancer.

  2026cites this paper
• Tr‐KIT Downstream Regulation by YY1 and NFYA Transcription Factors Knockdown in Prostate Cancer Cells

  2025cites this paper
• Demethylmycemycin A, a dibenzoxazepinone from the marine-derived Dactylosporangium sp. OK1079, with prostate cancer suppressive effects via targeting BRK-FAK-STAT3 axis

  2025cites this paper
• Circular RNA hsa_circ_0001610 promotes prostate cancer progression by sponging miR-1324 and upregulating PTK6.

  2024cites this paper
• A PROTAC degrader suppresses oncogenic functions of PTK6 inducing apoptosis of breast cancer cells.

  2024cites this paper
• Role of Sam68 in different types of cancer (Review)

  2024cites this paper
• Targeting Breast Cancer with Dasatinib Derivatives: A Multi-Parameter Strategy to Uncover Potent Lead Compounds

  2024cites this paper
• The Physiological and Pathophysiological Role of IL-6/STAT3-Mediated Signal Transduction and STAT3 Binding Partners in Therapeutic Applications.

  2023cites this paper
• Therapeutic Potential of Protein Tyrosine Kinase 6 in Colorectal Cancer

  2023cites this paper
• Brk/PTK6 and Involucrin Expression May Predict Breast Cancer Cell Responses to Vitamin D3

  2023cites this paper
• PTK6 inhibits autophagy to promote uveal melanoma tumorigenesis by binding to SOCS3 and regulating mTOR phosphorylation

  2023cites this paper
• METTL3 preferentially enhances non-m6A translation of epigenetic factors and promotes tumourigenesis

  2022cites this paper
• Protein tyrosine kinase 6 regulates activation of SRC kinase

  2022cites this paper
• Prognostic value of protein tyrosine kinase 6 overexpression in cancers: a meta-analysis.

  2022cites this paper
• Putting the BRK on breast cancer: From molecular target to therapeutics

  2021cites this paper
• An overview of breast cancer: Classification and related signaling pathways

  2021cites this paper
• PSPC1 is a new contextual determinant of aberrant subcellular translocation of oncogenes in tumor progression

  2021cites this paper
• Strategic Developments & Future Perspective on Gene therapy of Breast Cancer: Role of mTOR and Brk/ PTK6 as Molecular Targets.

  2020cites this paper
• Protein tyrosine kinase 6 signaling in prostate cancer.

  2020cites this paper
• Structure, Function, and Regulation of the SRMS Tyrosine Kinase

  2020cites this paper
• Targeting protein tyrosine kinase 6 in cancer.

  2020influential citation
• MicroRNA-214 targets PTK6 to inhibit tumorigenic potential and increase drug sensitivity of prostate cancer cells

  2019cites this paper
• Tr-KIT/c-KIT ratio in renal cell carcinoma

  2019cites this paper
• PSPC1-interchanged interactions with PTK6 and β-catenin synergize oncogenic subcellular translocations and tumor progression

  2019cites this paper
• 1 BRK ” ing ” Down All We Know About PTK 6 in Breast Cancer 2

  2018cites this paper
• Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers

  2018cites this paper
• Co-crystal structures of PTK6: With Dasatinib at 2.24 Å, with novel imidazo[1,2-a]pyrazin-8-amine derivative inhibitor at 1.70 Å resolution.

  2017cites this paper
• The stem cell factor (SCF)/c-KIT signalling in testis and prostate cancer

  2017cites this paper
• PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer

  2017cites this paper
• PTK6 (protein tyrosine kinase 6)

  2017cites this paper
• The expression and prognostic value of protein tyrosine kinase 6 in early-stage cervical squamous cell cancer

  2016cites this paper
• Altered stoichiometry and nuclear delocalization of NonO and PSF promote cellular senescence

  2016cites this paper
• PTK6 Inhibition Suppresses Metastases of Triple-Negative Breast Cancer via SNAIL-Dependent E-Cadherin Regulation.

  2016cites this paper
• Crystal structure of the kinase domain of human protein tyrosine kinase 6 (PTK6) at 2.33 Å resolution.

  2016cites this paper
• The role and mechanism of action of BRK in breast cancer progression

  2015cites this paper
• Additive impact of HER2‐/PTK6‐RNAi on interactions with HER3 or IGF‐1R leads to reduced breast cancer progression in vivo

  2015cites this paper
• SAM68: Signal Transduction and RNA Metabolism in Human Cancer

  2015cites this paper
• PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2+ breast cancer cells by inducing Bim

  2015cites this paper
• PTK6 Potentiates Gemcitabine-Induced Apoptosis by Prolonging S-phase and Enhancing DNA Damage in Pancreatic Cancer

  2015cites this paper
• Protein Tyrosine Kinase 6 Regulates UVB Induced Signaling and Tumorigenesis in Mouse Skin

  2015influential citation
• Breast tumor kinase/protein tyrosine kinase 6 (Brk/PTK6) activity in normal and neoplastic biliary epithelia.

  2015cites this paper
• Signal transducer and activator of transcription 3 regulation by novel binding partners.

  2015cites this paper
• Paradoxical and contradictory effects of imatinib in two cell line models of hormone‐refractory prostate cancer

  2015cites this paper
• EFFECTS OF FYN-RELATED-KINASE ACTIVITY ON BREAST CANCER CELL PROLIFERATION, MIGRATION, INVASION AND COLONY FORMATION

  2015cites this paper
• Brk/Protein Tyrosine Kinase 6 Phosphorylates p27KIP1, Regulating the Activity of Cyclin D–Cyclin-Dependent Kinase 4

  2015cites this paper
• Cancer-Associated Mutations in Breast Tumor Kinase/PTK6 Differentially Affect Enzyme Activity and Substrate Recognition.

  2015cites this paper
• Tracing the footprints of the breast cancer oncogene BRK - Past till present.

  2015cites this paper
• BRK Targets Dok1 for Ubiquitin-Mediated Proteasomal Degradation to Promote Cell Proliferation and Migration

  2014cites this paper
• Downregulated expression of PTK6 is correlated with poor survival in esophageal squamous cell carcinoma

  2014influential citation
• The SCF/c‐KIT system in the male: Survival strategies in fertility and cancer

  2014cites this paper
• PTK6 Promotes Cancer Migration and Invasion in Pancreatic Cancer Cells Dependent on ERK Signaling

  2014cites this paper
• HIF-1α-independent hypoxia-induced rapid PTK6 stabilization is associated with increased motility and invasion

  2014cites this paper
• Non-receptor protein tyrosine kinases signaling pathways in normal and cancer cells

  2014cites this paper
• Src: Marker or Actor in Prostate Cancer Aggressiveness

  2014cites this paper
• PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors

  2014cites this paper
• Activité cytotoxique in vitro et in vivo d'un extrait enrichi d'Helleborus caucasicus et mode d'action sur des cellules du cancer du poumon non-à-petites cellules

  2014cites this paper
• Signaling pathways in breast cancer: therapeutic targeting of the microenvironment.

  2014cites this paper
• Nonreceptor Tyrosine Kinases in Prostate

  2014cites this paper
• The Role of Protein Tyrosine Kinase 6 in the Mammary Gland Epithelium and Breast Cancer

  2014cites this paper
• Protein-tyrosine Phosphatase 1B Antagonized Signaling by Insulin-like Growth Factor-1 Receptor and Kinase BRK/PTK6 in Ovarian Cancer Cells*♦

  2013cites this paper
• Nuclear Odontogenic Ameloblast-Associated Protein (ODAM) Correlates with Melanoma Sentinel Lymph Node Metastasis

  2013cites this paper
• The unique N‐terminal region of SRMS regulates enzymatic activity and phosphorylation of its novel substrate docking protein 1

  2013cites this paper
• Protein tyrosine kinase 6 is associated with nasopharyngeal carcinoma poor prognosis and metastasis

  2013influential citation
• Low expression of PTK6/Brk predicts poor prognosis in patients with laryngeal squamous cell carcinoma

  2013cites this paper
• The role of QKI-5 in CG4 oligodendrocyte differentiation

  2013cites this paper
• INTERACTION BETWEEN BRK AND HER2 IN BREAST CANCER

  2013cites this paper
• Structure-function characterization of SRMS: Validation of Dok1 as a SRMS substrate

  2013cites this paper
• Protein tyrosine kinase 6 regulates mammary gland tumorigenesis in mouse models

  2013cites this paper
• PTK6 activation at the membrane regulates epithelial-mesenchymal transition in prostate cancer.

  2013cites this paper
• BRK / PTK 6 in Ovarian Cancer Cells Growth Factor-1 Receptor and Kinase Antagonized Signaling by Insulin-like Protein-tyrosine Phosphatase 1 B Signal Transduction :

  2013cites this paper
• Oncogenes and Tumor Suppressors Effects of Simultaneous Knockdown of HER 2 and PTK 6 on Malignancy and Tumor Progression in Human Breast Cancer Cells

  2013cites this paper
• Effects of Simultaneous Knockdown of HER2 and PTK6 on Malignancy and Tumor Progression in Human Breast Cancer Cells

  2013cites this paper
• Context‐specific protein tyrosine kinase 6 (PTK6) signalling in prostate cancer

  2013cites this paper
• Tyrosine Kinases in Prostate Cancer

  2013cites this paper
• Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.

  2012cites this paper
• Protein Tyrosine Kinase 6 Protects Cells from Anoikis by Directly Phosphorylating Focal Adhesion Kinase and Activating AKT

  2012cites this paper
• 'Protein tyrosine kinase-6 (PTK6)

  2012cites this paper
• Targeting Protein Tyrosine Kinase 6 Enhances Apoptosis of Colon Cancer Cells following DNA Damage

  2012cites this paper
• Constitutive activation of breast tumor kinase accelerates cell migration and tumor growth in vivo

  2012cites this paper
• Protein Tyrosine Kinase 6 Promotes Oncogenic Signaling at Cell Plasma Membrane in Prostate Cancer

  2012influential citation
• Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK

  2011cites this paper
• Detection of Brk expression in non-small cell lung cancer: clinicopathological relevance

  2011influential citation
• Roles of EEF1A2 & PTK6 in breast cancer

  2011cites this paper
• Discovery of novel imidazo[1,2-a]pyrazin-8-amines as Brk/PTK6 inhibitors.

  2011cites this paper
• The Alternative Splice Variant of Protein Tyrosine Kinase 6 Negatively Regulates Growth and Enhances PTK6-Mediated Inhibition of β-Catenin

  2011influential citation
• Disruption of the mouse protein tyrosine kinase 6 gene prevents STAT3 activation and confers resistance to azoxymethane.

  2011cites this paper
• Impact of protein tyrosine kinase 6 (PTK6) on human epidermal growth factor receptor (HER) signalling in breast cancer.

  2011cites this paper
• Future Therapeutic Strategies: Implications for Brk Targeting

  2011influential citation
• Protein-tyrosine Kinase 6 Promotes Peripheral Adhesion Complex Formation and Cell Migration by Phosphorylating p130 CRK-associated Substrate*

  2011cites this paper
• Interactions of STAP-2 with BRK and STAT3/5 in Breast Cancer Cells

  2011cites this paper
• Identifying Breast Cancer Oncogenes PRINCIPAL INVESTIGATOR:

  2011cites this paper
• Mechanisms of HGF/Met Signaling to Brk and Sam68 in Breast Cancer Progression

  2011cites this paper
• Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68.

  2010cites this paper
• Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells

  2010cites this paper
• PTK6 Regulates IGF-1-Induced Anchorage-Independent Survival

  2010cites this paper
• Targeting Tyrosine Kinases and Autophagy in Prostate Cancer

  2010cites this paper
• Brk/PTK6 signaling in normal and cancer cell models.

  2010cites this paper
• Comparative analysis of human SRC-family kinase substrate specificity in vitro.

  2010cites this paper
• Post-translational regulation of star proteins and effects on their biological functions.

  2010cites this paper
• Identification of β-catenin as a target of the intracellular tyrosine kinase PTK6

  2010cites this paper